Relatório global de análise do tamanho, quota e tendências do mercado de antibióticos animais antimicrobianos – Visão geral da indústria e previsão para 2031

Análise do mercado de antibióticos e antimicrobianos para animais

Nos últimos anos, tem-se assistido a um aumento do consumo de alimentos de origem animal, a uma procura crescente de produtos lácteos e a um aumento da população pecuária possibilitada pela agricultura organizada. Estes determinantes impulsionam ainda mais a procura de antibióticos antimicrobianos para animais. O crescimento da população geral de animais de companhia, especialmente a China, a Índia e o Brasil, leva à expansão substancial do mercado durante o período previsto.

Tamanho do mercado de antimicrobianos de antibióticos animais

O tamanho global do mercado de antibióticos antimicrobianos para animais foi avaliado em 4,88 mil milhões de dólares em 2023 e deverá atingir os 6,73 mil milhões de dólares até 2031, com um CAGR de 4,10% durante o período de previsão de 2024 a 2031 .

Âmbito do relatório e segmentação de mercado       

Definição do mercado de antimicrobianos de antibióticos animais

Antimicrobials are substances that kill or inhibit the majority of germs. The antimicrobials can be natural, semi-synthetic, or synthetic. Antibiotics are all antimicrobials, but antimicrobials aren't all antibiotics. Antibiotics are basically used to treat clinical illness, prevent and manage common disease occurrences, and improve animal development and growth. They are used in food animals in three ways: therapeutic, prophylactic, and sub-therapeutic.  Antimicrobials offer significant advantages in terms of animal and human food safety. Antibiotics and antimicrobials used in animals can contribute to the spread of antimicrobial resistance in bacteria that can be transmitted to people, reducing the efficacy of antimicrobial medications for treating human illnesses.

Animal Antibiotics Antimicrobials Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

• Growing Concerns For the Animal Health

There has been rising concerns regarding the health of animals. The rising animal healthcare spending and the growing demand for pet insurance will lead to high demand for animal antibiotics antimicrobials, which is the most significant factor driving the growth for this market. Increasing initiatives concerning animal health and welfare along with increasing incidence of zoonotic diseases are also expected to accelerate the overall growth of the market.

Furthermore, the rapid growth in the consumption of products such as meat and seafood on regular basis also triggers the market growth. The rising demand for animal-derived food products and the implementation of regulations to prevent the spread of animal diseases are also projected to cushion the growth of the market. Moreover, the unused prospects of the advancing markets and the development in the companion animal populace are estimated to generate lucrative opportunities for the market. The surging demand for dairy products, and subsequent rise in livestock population facilitated by organized farming which will further expand the animal antibiotics antimicrobials market's growth rate in the future.

Restraints/Challenges

• Strict Acceptance Process

There has been the increasing resistance to the antimicrobials. The strict acceptance procedure for the antimicrobials and antibiotics is expected to create hindrances for the market growth.

Also, the factors such as the shortage of the new antibiotics and the repetitive preventive utilization of the antibiotics being substituted by the good husbandry and the sanitization practices are projected to challenge the animal antibiotics antimicrobials market in the forecast period of 2024-2031.

This animal antibiotics antimicrobials market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the animal antibiotics antimicrobials market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post Covid-19 Impact on Animal Antibiotics Antimicrobials Market

The animal antibiotics antimicrobials market was moderately impacted by the outbreak of COVID-19. Imposition of the stringent lockdown and social distancing restrictions by the government to curb the COVID-19 pandemic outbreak, led to halt of various manufacturing operations, supply chain disruptions, stifling business growth, technology event cancellations, suspensions of new developments and has affected the overall production and sales, limiting the industry's expansion. The adoption of alternative sources, such as plant-based ingredients also hindered the growth of the market.

Moreover, the surge in Antimicrobial Resistance (AMR) in people and animals is projected in the post-COVID scenario, owing to increased demand on antibiotic-dependent healthcare systems to treat secondary bacterial infections. Antibiotic stewardship initiatives in hospitals and communities were interrupted, and antibiotics were prescribed for COVID patients misdiagnosed with bacterial bronchitis, over-prescription in telehealth consultations, and easy access to drugs from internet pharmacies were all linked to AMR. This is resulted in negative impact on consumers toward animal-sourced products.

Animal Antibiotics Antimicrobials Market Scope

The animal antibiotics antimicrobials market is segmented on the basis of product, mode of delivery and animal type. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Tetracycline
• Penicillin
• Sulfonamide
• Macrolide
• Cephalosporin
• Fluoroquinolone
• Lincosamides
• Cephalosporins

On the basis of product, the animal antibiotics antimicrobials market is segmented into tetracycline, penicillin, sulfonamide, macrolide, cephalosporin, fluoroquinolone, lincosamides and cephalosporins. The tetracyclines segment accounts for the largest share owing to its factors such as well-absorbed, low toxicity, high potency against pathogenic microorganisms and are relatively inexpensive compared to other animal antimicrobial and antibiotic products.

Mode of Delivery

• Premixes
• Oral Powder
• Injection
• Others

On the basis of mode of delivery, the animal antibiotics antimicrobials market is segmented into premixes, oral powder, injection and others.

Animal Type

• Food-producing Animals
• Companion Animals

On the basis of animal type, the animal antibiotics antimicrobials market is bifurcated into food-producing animals and companion animals.

Animal Antibiotics Antimicrobials Market Regional Analysis

The animal antibiotics antimicrobials market is analyzed and market size insights and trends are provided by country, product, mode of delivery and animal type as referenced above.

The countries covered in the animal antibiotics antimicrobials market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the animal antibiotics antimicrobials market because of the high companion animal ownership, increasing incidences of animal diseases coupled with the huge capital investments for the development of drugs for animal diseases within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2024 to 2031 due to the increasing government involvement in countering animal diseases outbreaks, increasing livestock population along with the growing demand for animal antimicrobials within the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Crescimento da infraestrutura de saúde Base instalada e penetração de novas tecnologias

O mercado de antimicrobianos de antibióticos animais também fornece análises de mercado detalhadas para o crescimento de cada país em despesas de saúde para equipamentos de capital, base instalada de diferentes tipos de produtos para o mercado de antimicrobianos de antibióticos animais, impacto da tecnologia utilizando curvas de linha de vida e as mudanças nos cenários regulamentares de saúde e o seu impacto no mercado de antibióticos antimicrobianos para animais. Os dados estão disponíveis para o período histórico 2010-2020.

Participação no mercado de antimicrobianos de antibióticos animais

O panorama competitivo do mercado de antibióticos antimicrobianos para animais fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado de antibióticos antimicrobianos para animais.

Os líderes de mercado de antibióticos antimicrobianos para animais que operam no mercado são:

• Boehringer Ingelheim International GmbH. (Alemanha)
• Zoetis (EUA)
• Elanco (EUA)
• (EUA)
• Phibro Animal Health Corporation (EUA)
• Virbac (França)
• Vetoquinol (França)
• HIPRA (Espanha)
• Ceva (França)
• Dechra (Reino Unido)
• Kyoritsuseiyaku Corporation (Japão)
• GRUPO DE MANUTENÇÃO ANIMAL DA CHINA (China)
• Endovac Saúde Animal (EUA)
• Grupo Zydus (Índia)
• Imunológicos Indianos Unip. Lda. (Índia)
• UCBVET Saúde e Bem-estar Animal (EUA)
• (EUA)
• Neogen Corporation (EUA)
• Huvepharma (EUA)
• Ayurveta (Índia)
• Ashish Life Science (Índia)
• Grupo Inovet (Bélgica)
• Lutim Pharma Private Limited (Índia)
• ECO Animal Health Ltd (EUA)

Últimos Desenvolvimentos no Mercado de Antimicrobianos de Antibióticos Animais

• Em julho de 2020, a Trianni Inc. (EUA) e a Zoetis (EUA) acordaram colaborar no desenvolvimento de plataformas de anticorpos monoclonais transgénicos para a identificação de novos medicamentos veterinários. A FDA autorizou a compra do Marboquin para a Zoetis (EUA).

SKU-10577